IL-18 expression has recently been detected in rheumatoid arthritis (RA) sy
novial membrane. We investigated the mechanisms by which IL-18-induced coll
agen-induced arthritis in DBA/1 mice primed intradermally with type II bovi
ne collagen in IFA and boosted i.p. 21 days later with CII in saline. Mice
were injected i.p. with rIL-12, rIL-18, or both (100 ng) during days -1 to
4 and again on days 20-24, Control mice received PBS. Mice treated with IL-
12 or IL-18 alone developed significantly higher incidence and more severe
disease compared with controls. These were elevated further by combination
treatment with IL-12 and IL-18, The cytokine treatments led to markedly enh
anced synovial hyperplasia, cellular infiltration, and cartilage erosion co
mpared with controls, Cytokine-treated mice produced significantly more IFN
-gamma, TNF-alpha and IL-6 than the controls. Interestingly, IL-18-treated
mice produced more TNF-alpha and IL-6, but less IFN-gamma, compared with mi
ce treated with IL-12, Furthermore, splenic macrophages from DBA/1 mice cul
tured in vitro with IL-18, but not IL-12, produced substantial amounts of T
NF-alpha, Mice treated with IL-18 or IL-18 plus IL-12 produced markedly mor
e IgG1 and IgG2a anti-collagen Ab compared with controls, whereas IL-12 tre
atment only led to an enhanced IgG2a response. Together these results demon
strate that IL-18 can promote collagen-induced inflammatory arthritis throu
gh mechanisms that may be distinct from those induced by IL-12.